Your browser doesn't support javascript.
loading
The 12p13.33/RAD52 locus and genetic susceptibility to squamous cell cancers of upper aerodigestive tract.
Delahaye-Sourdeix, Manon; Oliver, Javier; Timofeeva, Maria N; Gaborieau, Valérie; Johansson, Mattias; Chabrier, Amélie; Wozniak, Magdalena B; Brenner, Darren R; Vallée, Maxime P; Anantharaman, Devasena; Lagiou, Pagona; Holcátová, Ivana; Richiardi, Lorenzo; Kjaerheim, Kristina; Agudo, Antonio; Castellsagué, Xavier; Macfarlane, Tatiana V; Barzan, Luigi; Canova, Cristina; Thakker, Nalin S; Conway, David I; Znaor, Ariana; Healy, Claire M; Ahrens, Wolfgang; Zaridze, David; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Fabianova, Eleonora; Mates, Ioan Nicolae; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Curado, Maria Paula; Koifman, Sergio; Menezes, Ana; Wünsch-Filho, Victor; Eluf-Neto, José; Boffetta, Paolo; Garrote, Leticia Fernández; Serraino, Diego; Lener, Marcin; Jaworowska, Ewa; Lubinski, Jan; Boccia, Stefania; Rajkumar, Thangarajan; Samant, Tanuja A; Mahimkar, Manoj B; Matsuo, Keitaro; Franceschi, Silvia; Byrnes, Graham.
Afiliação
  • Delahaye-Sourdeix M; Genetic Cancer Susceptibility group (GCS), International Agency for Research on Cancer (IARC), Lyon, France.
  • Oliver J; Genetic Cancer Susceptibility group (GCS), International Agency for Research on Cancer (IARC), Lyon, France.
  • Timofeeva MN; Genetic Epidemiology group (GEP), International Agency for Research on Cancer (IARC), Lyon, France; Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, United Kingdom.
  • Gaborieau V; Genetic Epidemiology group (GEP), International Agency for Research on Cancer (IARC), Lyon, France.
  • Johansson M; Genetic Epidemiology group (GEP), International Agency for Research on Cancer (IARC), Lyon, France.
  • Chabrier A; Genetic Cancer Susceptibility group (GCS), International Agency for Research on Cancer (IARC), Lyon, France.
  • Wozniak MB; Genetic Epidemiology group (GEP), International Agency for Research on Cancer (IARC), Lyon, France.
  • Brenner DR; Genetic Epidemiology group (GEP), International Agency for Research on Cancer (IARC), Lyon, France.
  • Vallée MP; Genetic Cancer Susceptibility group (GCS), International Agency for Research on Cancer (IARC), Lyon, France.
  • Anantharaman D; Genetic Epidemiology group (GEP), International Agency for Research on Cancer (IARC), Lyon, France.
  • Lagiou P; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens School of Medicine, Athens, Greece.
  • Holcátová I; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Richiardi L; University of Turin, Department of Medical Sciences, Unit of Cancer Epidemiology, Turin, Italy.
  • Kjaerheim K; Cancer Registry of Norway, Oslo, Norway.
  • Agudo A; Catalan Institute of Oncology-ICO, IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.
  • Castellsagué X; Catalan Institute of Oncology-ICO, IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Macfarlane TV; School of Medicine and Dentistry, University of Aberdeen, Aberdeen, United Kingdom.
  • Barzan L; General Hospital of Pordenone, Pordenone, Italy.
  • Canova C; Department of Environmental Medicine and Public Health, University of Padova, Padova, Italy; MRC-HPA Centre for Environment and Health, Respiratory Epidemiology and Public Health, National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Thakker NS; University of Manchester, School of Dentistry, Manchester, United Kingdom.
  • Conway DI; University of Glasgow Dental School, Glasgow, Scotland, United Kingdom.
  • Znaor A; Croatian National Cancer Registry, Croatian National Institute of Public Health, Zagreb, Croatia.
  • Healy CM; Trinity College School of Dental Science, Dublin, Ireland.
  • Ahrens W; Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany; Faculty of Mathematics and Computer Science, University of Bremen, Bremen, Germany.
  • Zaridze D; Institute of Carcinogenesis, Cancer Research Centre, Moscow, Russian Federation.
  • Szeszenia-Dabrowska N; Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland.
  • Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Fabianova E; Regional Authority of Public Health, Banska Bystrica, Slovakia.
  • Mates IN; Saint Mary General and Esophageal Surgery Clinic, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Bencko V; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic.
  • Janout V; Palacky University, Olomouc, Czech Republic.
  • Curado MP; International Prevention Research Institute (IPRI), Ecully, France.
  • Koifman S; National School of Public Health/FIOCRUZ, Rio de Janeiro, Brazil.
  • Menezes A; Universidade Federal de Pelotas, Pelotas, Brazil.
  • Wünsch-Filho V; Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Eluf-Neto J; Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Boffetta P; The Tisch Cancer Institute Mount Sinai School of Medicine, New York, NY, United States of America.
  • Garrote LF; Institute of Oncology and Radiobiology, Havana, Cuba.
  • Serraino D; Centro di Riferimento Oncologico, IRCSS, Unit of Epidemiology and Biostatistics, Aviano, Italy.
  • Lener M; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Jaworowska E; Department of Otolaryngology and Laryngological Oncology, Pomeranian Medical University, Szczecin, Poland.
  • Lubinski J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Boccia S; Institute of Public Health, Section of Hygiene, Faculty of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Rajkumar T; Dept. of Molecular Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
  • Samant TA; Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Mahimkar MB; Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Matsuo K; Department of Health Promotion, Division of Oral Pathology, Kyushu Dental University, Kitakyushu, Japan.
  • Franceschi S; Infections and Cancer Epidemiology group (ICE), International Agency for Research on Cancer (IARC), Lyon, France.
  • Byrnes G; Biostatistics group (BST), International Agency for Research on Cancer (IARC), Lyon, France.
PLoS One ; 10(3): e0117639, 2015.
Article em En | MEDLINE | ID: mdl-25793373
ABSTRACT
Genetic variants located within the 12p13.33/RAD52 locus have been associated with lung squamous cell carcinoma (LUSC). Here, within 5,947 UADT cancers and 7,789 controls from 9 different studies, we found rs10849605, a common intronic variant in RAD52, to be also associated with upper aerodigestive tract (UADT) squamous cell carcinoma cases (OR = 1.09, 95% CI 1.04-1.15, p = 6x10(-4)). We additionally identified rs10849605 as a RAD52 cis-eQTL inUADT(p = 1x10(-3)) and LUSC (p = 9x10(-4)) tumours, with the UADT/LUSC risk allele correlated with increased RAD52 expression levels. The 12p13.33 locus, encompassing rs10849605/RAD52, was identified as a significant somatic focal copy number amplification in UADT(n = 374, q-value = 0.075) and LUSC (n = 464, q-value = 0.007) tumors and correlated with higher RAD52 tumor expression levels (p = 6x10(-48) and p = 3x10(-29) in UADT and LUSC, respectively). In combination, these results implicate increased RAD52 expression in both genetic susceptibility and tumorigenesis of UADT and LUSC tumors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 12 / Carcinoma de Células Escamosas / Predisposição Genética para Doença / Proteína Rad52 de Recombinação e Reparo de DNA / Loci Gênicos / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 12 / Carcinoma de Células Escamosas / Predisposição Genética para Doença / Proteína Rad52 de Recombinação e Reparo de DNA / Loci Gênicos / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article